HIV/AIDS: Antiretroviral Therapy for Hepatitis B Virus–HIV–Coinfected Patients: Promises and Pitfalls-Reference-Cited by-同舟云学术

HIV/AIDS: Antiretroviral Therapy for Hepatitis B Virus–HIV–Coinfected Patients: Promises and Pitfalls

Published:2006-10 Issue:7 Volume:43 Page:904-910
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Levy Vivian,Grant Robert M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/43/7/904/1056021/43-7-904.pdf

Reference45 articles.

1. Prevalence of Chronic Hepatitis B and Incidence of Acute Hepatitis B Infection in Human Immunodeficiency Virus–Infected Subjects

2. Centers for Disease Control and Prevention. Hepatitis B slide set. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/index.htm. Accessed 1 March 2006.

3. UNAIDS/WHO. HIV prevalence in adults, end 2003. Available at: http://data.unaids.org/Topics/Epidemiology/Slides02/AdultPrevJuly04Global_en.ppt#1. Accessed 15 February 2006.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Modern Antiretroviral Therapy in the Intensive Care Unit: Overcoming Challenges for Critically Ill People With Human Immunodeficiency Virus;Open Forum Infectious Diseases;2024-04-17

2. An update on the bioactivities and health benefits of two plant-derived lignans, phyllanthin and hypophyllanthin;Advances in Traditional Medicine;2024-01-27

3. Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent;RSC Advances;2023

4. A review on the epidemiology of HBV and HIV co-infection;CHRISMED Journal of Health and Research;2023

5. Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals;Vaccines;2021-12-15